Skip to main content
. 2009 Sep 11;297(5):H1661–H1672. doi: 10.1152/ajpheart.00432.2009

Fig. 6.

Fig. 6.

Comparison of plasma vasopressin levels measured before (pre) and after (post) microinjections into the NTS of vehicle (ACF; n = 5) or selective A1 adenosine receptor agonist (CPA; n = 8). *Differences between pre- vs. postmicroinjections (P < 0.05); #differences between the groups (P < 0.05). CPA increased circulating vasopressin levels over 4-fold, whereas ACF did not significantly increase the level of circulating vasopressin.